name: Bioavailability_Ma_et_al
description: "Oral bioavailability is defined as the rate and extent to which\
  \ the active ingredient or active moiety is absorbed from a drug product and becomes\
  \ available at the site of action."
targets:
- id: bioavailable
  description: whether it available at the site of action (1) or not (0)
  units: bioavailable
  type: categorical
  names:
  - Oral bioavailability
  - bioavailability
  - ADME bioavailability
  - Drug delivery
  uris:
  - https://bioportal.bioontology.org/ontologies/NCIT?p=classes&conceptid=http%3A%2F%2Fncicb.nci.nih.gov%2Fxml%2Fowl%2FEVS%2FThesaurus.owl%23C70913
identifiers:
- id: SMILES
  type: SMILES
  description: SMILES
- id: compound_name
  type: Other
  description: Drug name
license: CC BY 4.0
links:
- url: https://doi.org/10.1016/j.jpba.2008.03.023
  description: corresponding publication
- url: https://tdcommons.ai/single_pred_tasks/adme/#bioavailability-ma-et-al
  description: data source
num_points: 640
bibtex:
- "@article{Ma2008,\n  doi = {10.1016/j.jpba.2008.03.023},\n  url = {https://doi.org/10.1016/j.jpba.2008.03.023},\n\
  \  year = {2008},\n  month = aug,\n  publisher = {Elsevier {BV}},\n  volume = {47},\n\
  \  number = {4-5},\n  pages = {677--682},\n  author = {Chang-Ying Ma and Sheng-Yong\
  \ Yang and Hui Zhang and Ming-Li Xiang and Qi Huang and Yu-Quan Wei},\n  title =\
  \ {Prediction models of human plasma protein binding rate and oral bioavailability\
  \ derived by using {GA}{\textendash}{CG}{\textendash}{SVM} method},\n  journal =\
  \ {Journal of Pharmaceutical and Biomedical Analysis}}"
